Trademark: 77255521
Word
NANORISK
Status
Dead
Status Code
606
Status Date
Monday, June 28, 2010
Serial Number
77255521
Mark Type
4000
Filing Date
Wednesday, August 15, 2007
Published for Opposition
Tuesday, September 2, 2008
Abandoned Date
Monday, June 28, 2010

Trademark Owner History
nanoLife Sciences, Inc. - Owner At Publication

Classifications
1 Biological preparations for scientific research purposes, namely, biological tissues or cell lines for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; proteins, peptide substrates, or enzymes for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; chemical test kits containing biological tissues, cell lines, proteins, peptide substrates, or enzymes for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; chemical preparations for scientific analysis purposes, namely, reagents for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; test kits containing chemical reagents for non-medical purposes, namely, for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; chemical preparations for scientific purposes, namely, chemical formulations for the solubilization, stabilization, or activation of nanoscale materials for use in presentation of nanoscale materials to various biological, physical, or chemical test systems to facilitate identification or assessment of nanoscale materials or biological interactions with nanoscale materials; diagnostic preparations for scientific use
5 Biological diagnostic preparations for medical analysis use; chemical preparations for medical use, namely, chelators and scavengers for removing or diagnosing toxic nanoparticles; diagnostic preparations for medical use
9 Software programs and downloadable software programs for use in risk assessment of nanomaterials, nanodevices and toxicology; scientific apparatus, instruments and devices for research and examination purposes, namely, lab-on-a-chip devices comprising microfluidics for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; gene microarrays comprising of oligo nucleotides for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; biosensors using chemical, electrochemical, biochemical, enzymatic, chromatographic, spectroscopic, or mass spectral detection methods for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; computers programmed with relational or expert databases of nanoscale material identification or assessment information for use in identification or assessment of nanoscale materials or biological interactions with nanoscale materials; laboratory equipment, measuring apparatus and instruments, namely, nanoscale material generation systems for introduction of nanoscale materials into physical, chemical, biochemical, or biological test systems comprised of dust generators for generating in vitro and in vivo exposures to nanoparticulates for inhalation exposures at toxicologic, pharmacologic, or therapeutic airborne concentrations, vaporizers, nebulizers and sprayers all for use in generating in vitro and in vivo exposures to droplets and other particles containing nanomaterials for inhalation exposures at toxicologic, pharmacologic or therapeutic concentrations, mixers for preparing test materials in solution, semi-solids or solids for exposures or doses of nanomaterials in vitro or in vivo experimental tests of a biological or clinical nature, incubators for creating and maintaining controlled test environments; pipettors, disposable syringes and containers and containment devices designed to retain, and deliver nanomaterials in liquid, semi-solid or solid dosage forms and for chemical analysis of dosage forms and biological samples from toxicologic or pharmacologic exposures in vitro and in vivo, and microplates designed to contain nanomaterials to avoid physicochemical, chemical, physical or electromagnetic effects that would interfere with precise measurements of toxicologic or pharmacologic endpoints; photometric test systems for use in the identification or assessment of nanoscale materials comprised of microplate readers, photomicroscopes, uv/vis photometers and photometric detectors, infrared photometers, photometric detectors, x-ray, gamma-ray, photo fluorescence and magnetic resonance imaging equipment; environmental sampling devices or systems for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials comprised of dust and particulate impact collectors, electrostatic precipitators, water filtration collectors, centrifugal collection devices, air filtration devices and collectors, size exclusion separators, mass spectrometric air sampling systems comprised of mass selective or multiple detectors; photometric air and water sampling systems comprised of air or water sampling chambers with infrared, visible, ultraviolet, fluorescent or laser photometric means of nanoparticulate detection, x-ray diffraction and x-ray fluorescence sampling systems comprised of a variable x-ray source, nanomaterials containment or targeting device and an x-ray detector, liquid and chromatographic sampling systems comprised of an electronically or hydraulically controlled liquid sampling loop to deliver nanomaterials and a microprocessor-controlled microplate or vial in rack-type sample collector; all of the above goods are intended for scientific and laboratory research purposes and not medical purposes
41 Teaching, training and educational services, namely, classes, seminars, workshops in the field of risk assessment of nanomaterials, nanodevices and toxicology
42 Scientific research and development for others in the fields of life sciences, biotechnology, toxicology, and genomics; chemical and toxicological analysis service; computer services, namely, providing online databases and websites featuring reports in the field of risk assessment of nanomaterials, nanodevices and toxicology
NANO RISK

Trademark Events
Jul 22, 2010
Attorney Revoked And/Or Appointed
Jul 22, 2010
Teas Revoke/Appoint Attorney Received
Jun 28, 2010
Abandonment Notice Mailed - No Use Statement Filed
Jun 28, 2010
Abandonment - No Use Statement Filed
Jan 28, 2010
Extension 2 Granted
Nov 23, 2009
Extension 2 Filed
Jan 13, 2010
Case Assigned To Intent To Use Paralegal
Nov 23, 2009
Teas Extension Received
May 25, 2009
Extension 1 Granted
May 25, 2009
Extension 1 Filed
May 25, 2009
Teas Extension Received
Nov 25, 2008
Noa Mailed - Sou Required From Applicant
Sep 2, 2008
Published For Opposition
Aug 13, 2008
Notice Of Publication
Jul 28, 2008
Law Office Publication Review Completed
Jul 24, 2008
Examiners Amendment Mailed
Jul 24, 2008
Approved For Pub - Principal Register
Jul 24, 2008
Examiner's Amendment Entered
Jul 24, 2008
Examiners Amendment -Written
Jul 1, 2008
Previous Allowance Count Withdrawn
Jun 27, 2008
Withdrawn From Pub - Og Review Query
Jun 18, 2008
Law Office Publication Review Completed
Jun 18, 2008
Assigned To Lie
Jun 18, 2008
Approved For Pub - Principal Register
Jun 16, 2008
Examiners Amendment Mailed
Jun 13, 2008
Examiner's Amendment Entered
Jun 13, 2008
Examiners Amendment -Written
May 19, 2008
Teas/Email Correspondence Entered
May 19, 2008
Correspondence Received In Law Office
May 19, 2008
Teas Response To Office Action Received
Mar 20, 2008
Attorney Revoked And/Or Appointed
Mar 20, 2008
Teas Revoke/Appoint Attorney Received
Nov 26, 2007
Non-Final Action Mailed
Nov 24, 2007
Non-Final Action Written
Nov 23, 2007
Assigned To Examiner
Aug 20, 2007
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24